---
figid: PMC3021942__nihms261138f2
figlink: /pmc/articles/PMC3021942/figure/F2/
number: Figure 2
caption: Current working model of convergent pathways to PMF. The “Q” pathway (left,
  black arrows) is elicited by intermittent activation of Gq-coupled metabotropic
  receptors (e.g. 5-HT2 or α1). Subsequent activation of protein kinase C (PKC) initiates
  new BDNF synthesis and increases NADPH oxidase (NOX) activity. BDNF activates TrkB
  and then ERK MAP kinases (pERK). Protein phosphatases (PP2/5) normally constrain
  pLTF, but are regulated via NADPH oxidase (NOX) dependent ROS formation. The “S”
  pathway (right; white arrows) is elicited by Gs-coupled metabotropic receptors (eg.
  5-HT7 and A2A) coupled to protein kinase A (PKA). PKA may induce new synthesis of
  an immature TrkB isoform, which auto-phosphorylates and signals from inside the
  cell via Akt activation (pAkt). We postulate that both pERK and pAkt phosphorylate
  glutamate receptors, thereby giving rise to greater synaptic strength and PMF. We
  cannot rule out changes in motor neuron excitability as a cause of PMF, for example
  via membrane insertion of ion channels.
pmcid: PMC3021942
papertitle: Multiple Pathways to Long-lasting Phrenic Motor Facilitation.
reftext: Erica A. Dale-Nagle, et al. Adv Exp Med Biol. ;669:225-230.
pmc_ranked_result_index: '121016'
pathway_score: 0.9361845
filename: nihms261138f2.jpg
figtitle: Current working model of convergent pathways to PMF
year: ''
organisms: Homo sapiens
ndex: a22857d2-def8-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3021942__nihms261138f2.html
  '@type': Dataset
  description: Current working model of convergent pathways to PMF. The “Q” pathway
    (left, black arrows) is elicited by intermittent activation of Gq-coupled metabotropic
    receptors (e.g. 5-HT2 or α1). Subsequent activation of protein kinase C (PKC)
    initiates new BDNF synthesis and increases NADPH oxidase (NOX) activity. BDNF
    activates TrkB and then ERK MAP kinases (pERK). Protein phosphatases (PP2/5) normally
    constrain pLTF, but are regulated via NADPH oxidase (NOX) dependent ROS formation.
    The “S” pathway (right; white arrows) is elicited by Gs-coupled metabotropic receptors
    (eg. 5-HT7 and A2A) coupled to protein kinase A (PKA). PKA may induce new synthesis
    of an immature TrkB isoform, which auto-phosphorylates and signals from inside
    the cell via Akt activation (pAkt). We postulate that both pERK and pAkt phosphorylate
    glutamate receptors, thereby giving rise to greater synaptic strength and PMF.
    We cannot rule out changes in motor neuron excitability as a cause of PMF, for
    example via membrane insertion of ion channels.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKCH
  - PRKCA
  - PRKAR2B
  - PRKACA
  - PRKAR1B
  - EIF2AK3
  - PRKCB
  - PRKCD
  - BDNF
  - PRKAR1A
  - GNA14
  - GNAL
  - PRKD3
  - GNAQ
  - PRKCI
  - HTR7
  - PRKACB
  - PRKAR2A
  - PRKACG
  - PRB1
  - PRKCZ
  - GNA15
  - PRKCG
  - PRKCE
  - GNA11
  - GNAS
  - NTRK2
  - PRKCQ
genes:
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PERK/pAkt
  symbol: PERK
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK3
  entrez: '9451'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: BDNF
  symbol: BDNF
  source: hgnc_symbol
  hgnc_symbol: BDNF
  entrez: '627'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: Gq
  symbol: Gq
  source: bioentities_symbol
  hgnc_symbol: GNA14
  entrez: '9630'
- word: Gs
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAL
  entrez: '2774'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: Gq
  symbol: Gq
  source: bioentities_symbol
  hgnc_symbol: GNAQ
  entrez: '2776'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: 5-HT7
  symbol: 5-HT7
  source: hgnc_alias_symbol
  hgnc_symbol: HTR7
  entrez: '3363'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PMF
  symbol: PMF
  source: hgnc_alias_symbol
  hgnc_symbol: PRB1
  entrez: '5542'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: Gq
  symbol: Gq
  source: bioentities_symbol
  hgnc_symbol: GNA15
  entrez: '2769'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: Gq
  symbol: Gq
  source: bioentities_symbol
  hgnc_symbol: GNA11
  entrez: '2767'
- word: Gs
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAS
  entrez: '2778'
- word: TrkB
  symbol: TRKB
  source: hgnc_alias_symbol
  hgnc_symbol: NTRK2
  entrez: '4915'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
chemicals: []
diseases: []
---
